Purdue Pharma’s marketing of OxyContin in the late 1990s marked the beginning of the industry’s push to promote narcotic painkillers for treatment of chronic pain — an indication for which both safety and efficacy remain unproven.

The link address is: http://www.medpagetoday.com/Neurology/PainManagement/34650